Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
From the FDA notice · Read the official notice ↗ · All Fresenius Kabi recalls
What to do
The agency's notice has the remedy and who to contact.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- 2,199,850 vials
- Illnesses reported
- None reported
- Manufactured in
- 3 Corporate Dr, N/A, Lake Zurich, IL, United States
- Classification
- Class I
- Recall number
- D-0182-2026
In the FDA's words
- Description
- Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale). Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026. Distribution: Nationwide within the United States as well as AK, HI, and PR. Affected quantity: 2,199,850 vials
- Hazard
- Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
More from Fresenius Kabi
See all- Tyenne (tocilizumab-aazg) injection recalled for glass particles
SeriousFDASep 2, 2026
- Fresenius Kabi morphine syringes recalled for Dilaudid label mixup
SeriousFDAAug 26, 2026